The Drug-Induced Respiratory Disease Website
Can be fatal (PMID 29735504)
Publications
Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.
Cancer treatment and research communications 2018;15;17-20 — 2018 — 17-20
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Cs?szi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR,
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
The New England journal of medicine 2016 11 10;375;1823-1833 — 2016 11 10 — 1823-1833
Goldberg SB, Gettinger SN, Mahajan A, Chiang AC, Herbst RS, Sznol M, Tsiouris AJ, Cohen J, Vortmeyer A, Jilaveanu L, Yu J, Hegde U, Speaker S, Madura M, Ralabate A, Rivera A, Rowen E, Gerrish H, Yao X, Chiang V, Kluger HM
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
The Lancet. Oncology 2016 Jul;17;976-983 — 2016 Jul — 976-983